文献速递传染病防控与疫情报告免疫规划

带状疱疹与2019冠状病毒病的关系:自身对照病例系列研究

Relationship between shingles and coronavirus disease 2019: a self-controlled case series study.
PubMed 文献 · Int J Epidemiol · 2025-01-01

基于日本住院和门诊索赔数据库,纳入2020年1月1日至2023年1月30日的399381例COVID-19患者,其中558例在诊断前后90天内发生带状疱疹并接受抗病毒治疗。采用自身对照病例系列方法,发现感染后第1-2周带状疱疹发生率比对照期显著升高(IRR 5.1,95%CI 3.9-6.6),第3-4周和第5-6周亦升高。结论提示带状疱疹可能与COVID-19相关,并强调在COVID-19时代需同时接种水痘-带状疱疹疫苗。

要点

  • COVID-19感染后第1-2周带状疱疹发生率显著升高(IRR 5.1,95%CI 3.9-6.6)。
  • 第3-4周(IRR 1.7,95%CI 1.2-2.5)和第5-6周(IRR 1.5,95%CI 1.0-2.3)发生率仍高于对照期。
  • 作者认为带状疱疹可能是该病毒的特征之一,并强调需同时接种水痘-带状疱疹疫苗。

核心结论

  • 基于日本住院和门诊数据库的自身对照病例系列研究显示带状疱疹与COVID-19存在关联,提示带状疱疹可能是该病毒的特征之一,并强调在COVID-19时代需同时接种水痘-带状疱疹疫苗。

研究设计与样本

  • 自身对照病例系列研究,使用日本住院和门诊索赔数据库,识别2020年1月1日至2023年1月30日期间诊断为COVID-19的患者。
  • 在COVID-19诊断前后90天内识别发生带状疱疹并接受抗病毒治疗的患者,共纳入399381例COVID-19患者,其中558例诊断为带状疱疹。

主要发现

  • 与对照期相比,COVID-19感染后第1-2周带状疱疹发生率比(IRR)为5.1(95%CI 3.9-6.6)。
  • 与对照期相比,COVID-19感染后第3-4周IRR为1.7(95%CI 1.2-2.5)。
  • 与对照期相比,COVID-19感染后第5-6周IRR为1.5(95%CI 1.0-2.3)。

临床怎么用

  • 作者认为带状疱疹可能是COVID-19病毒的特征之一,并强调在COVID-19时代需同时接种水痘-带状疱疹疫苗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although some studies suggest an increased risk of shingles following coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, no research has examined this relationship in real-world clinical settings. We aimed to investigate the association between shingles and COVID-19 by using a Japanese inpatient and outpatient claims database. METHODS: We identified patients with COVID-19 from 1 January 2020 to 30 January 2023 by using a Japanese inpatient and outpatient claims database. We also identified those who developed shingles and received antiviral drugs within 90 days before or after their COVID-19 diagnosis. Using self-controlled case series methods, we evaluated the relationship between shingles and COVID-19. We calculated the incidence rate ratio (IRR) [95% confidence interval (CI)] for shingles during the buffer period (days -35 to -7), pre-exposure period (days -6 to 0), and risk periods of the first and second, third and fourth, and fifth and sixth weeks following COVID-19 infection compared with a control period outside these intervals. RESULTS: Among 399 381 patients with COVID-19, 558 were diagnosed with shingles. The IRR was significantly elevated during the first and second (5.1, 95% CI 3.9-6.6), third and fourth (1.7, 95% CI 1.2-2.5), and fifth and sixth weeks (1.5, 95% CI 1.0-2.3) compared with a control period. CONCLUSION: This study of a Japanese inpatient and outpatient database reveals a relationship between shingles and COVID-19, indicating that shingles may be a characteristic of the virus and highlighting the need for varicella-zoster vaccination alongside SARS-CoV-2 in the COVID-19 era.

来源:Int J Epidemiol,查看原文。版权归原作者所有。

引用

  1. Mizuno T, Suzuki J, Takahashi S, et al. Relationship between shingles and coronavirus disease 2019: a self-controlled case series study. Int J Epidemiol. 2025. PMID: 41005961. doi:10.1093/ije/dyaf162

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。